Ayrton Capital LLC 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 1:44 pm Sale |
2024-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 657,614 6.200% |
-15,296 (-2.27%) |
Filing |
| 2024-11-14 5:17 pm Purchase |
2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 672,910 6.500% |
428,619 (+175.45%) |
Filing |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 244,291 9.900% |
244,291 (New Position) |
Filing |